Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $21,403 | $21,960 | $23,565 | $20,975 |
| % Growth | -2.5% | -6.8% | 12.3% | – |
| Cost of Goods Sold | $12,728 | $11,506 | $13,461 | $11,736 |
| Gross Profit | $8,675 | $10,454 | $10,104 | $9,239 |
| % Margin | 40.5% | 47.6% | 42.9% | 44% |
| R&D Expenses | $0 | $0 | $162 | $0 |
| G&A Expenses | $2,058 | $1,895 | $1,776 | $0 |
| SG&A Expenses | $5,622 | $5,370 | $5,102 | $4,959 |
| Sales & Mktg Exp. | $3,564 | $3,475 | $3,326 | $0 |
| Other Operating Expenses | $0 | $5,073 | $0 | $0 |
| Operating Expenses | $5,622 | $10,443 | $6,606 | $4,959 |
| Operating Income | $3,053 | $11 | $3,498 | $4,280 |
| % Margin | 14.3% | 0.1% | 14.8% | 20.4% |
| Other Income/Exp. Net | -$6,361 | $3,174 | -$2,095 | -$1,395 |
| Pre-Tax Income | -$3,308 | $3,185 | $1,403 | $2,885 |
| Tax Expense | $163 | $797 | $358 | $589 |
| Net Income | -$3,471 | $2,388 | $1,045 | $2,296 |
| % Margin | -16.2% | 10.9% | 4.4% | 10.9% |
| EPS | -7.82 | 5.38 | 2.35 | 5.09 |
| % Growth | -245.4% | 128.9% | -53.8% | – |
| EPS Diluted | -7.82 | 5.38 | 2.35 | 5.09 |
| Weighted Avg Shares Out | 444 | 444 | 444 | 444 |
| Weighted Avg Shares Out Dil | 444 | 444 | 444 | 444 |
| Supplemental Information | – | – | – | – |
| Interest Income | $186 | $0 | $584 | $464 |
| Interest Expense | $888 | $652 | $620 | $951 |
| Depreciation & Amortization | $1,050 | $1,039 | $465 | $937 |
| EBITDA | -$2,258 | $4,935 | $5,857 | $5,217 |
| % Margin | -10.5% | 22.5% | 24.9% | 24.9% |